Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Other Working Capital Changes (2019 - 2025)

Historic Other Working Capital Changes for Korro Bio (KRRO) over the last 7 years, with Q3 2025 value amounting to -$271000.0.

  • Korro Bio's Other Working Capital Changes rose 4569.14% to -$271000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $7.3 million, marking a year-over-year increase of 14076.9%. This contributed to the annual value of $9.4 million for FY2024, which is 37433.32% up from last year.
  • Per Korro Bio's latest filing, its Other Working Capital Changes stood at -$271000.0 for Q3 2025, which was up 4569.14% from -$371000.0 recorded in Q2 2025.
  • In the past 5 years, Korro Bio's Other Working Capital Changes ranged from a high of $8.5 million in Q4 2024 and a low of -$9.4 million during Q2 2021
  • Moreover, its 5-year median value for Other Working Capital Changes was -$251000.0 (2022), whereas its average is -$223588.2.
  • In the last 5 years, Korro Bio's Other Working Capital Changes surged by 55537.19% in 2024 and then tumbled by 31586.21% in 2025.
  • Korro Bio's Other Working Capital Changes (Quarter) stood at -$9.4 million in 2021, then skyrocketed by 135.21% to $3.3 million in 2022, then tumbled by 35.95% to $2.1 million in 2023, then soared by 301.69% to $8.5 million in 2024, then plummeted by 103.18% to -$271000.0 in 2025.
  • Its last three reported values are -$271000.0 in Q3 2025, -$371000.0 for Q2 2025, and -$626000.0 during Q1 2025.